Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advisory Committees Free Of Conflicts May Be Unfeasible, FDA Review Says

This article was originally published in The Tan Sheet

Executive Summary

FDA's policy of granting waivers for financial conflicts of interest for advisory committee members is supported by an independent review commissioned by the agency, which determined that constructing advisory committees free from conflicts of interest would be expensive and time-consuming and may be unfeasible for certain topics and fields of expertise

You may also be interested in...



Advisory Committee Policy Allows Members With Financial Conflicts To Vote

FDA advisory committee participants with personal financial conflicts of interest may fully participate in committee meetings, according to the agency's latest conflict of interest policy

Advisory Committee Policy Allows Members With Financial Conflicts To Vote

FDA advisory committee participants with personal financial conflicts of interest may fully participate in committee meetings, according to the agency's latest conflict of interest policy

Advisory Committee Policy Allows Members With Financial Conflicts To Vote

FDA advisory committee participants with personal financial conflicts of interest may fully participate in committee meetings, according to the agency's latest conflict of interest policy

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS101168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel